HB1236

Provides relative to pharmacy benefit managers reimbursements (EN +$2,265,844 SG EX See Note)

Complete·6/12/26

Louisiana HB1236 amends pharmacy benefit manager reimbursement guidelines, ensuring pharmacies receive adequate compensation for prescription drugs.

Louisiana HB1236 revises pharmacy benefit manager reimbursement guidelines to ensure pharmacies receive adequate compensation for prescription drugs. The bill amends the definition of "acquisition cost" and introduces the term "professional dispensing fee." It mandates that pharmacy benefit managers use either the National Average Drug Acquisition Costs (NADAC) or wholesale acquisition cost as the prescription drug pricing benchmark. If NADAC is unavailable, pharmacy benefit managers must use the local pharmacy's documented invoice cost or wholesale acquisition cost.

Included in complete analysis

  • Overview
  • Core Provisions
  • Implementation
  • Impact
  • Legal Framework
  • Critical Issues

See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.

Sponsors

0
2
RR
Democratic CaucusRepublican Caucus

Roll Call Votes

93 Yea

DDDRDRRRRRRDRRRDRDRDRRDDRRRRRDDRRRRRRRRRRRRRRRRRRDRRDRRRDDRRRRRRDRRRRRRRDDRRRRDRRDDDDRRDRDRRR

0 Nay

12 Absent

RDDRRDRRRDDD

Calendar

May 11

10:30 AM

Senate Committee on Finance

May 6

9:30 AM

Senate Committee on Insurance

History

Jun 12

House

Signed by the Governor. Becomes Act No. 913.

Jun 12

House

Effective date: 06/12/2026.

Jun 4

House

Sent to the Governor for executive approval.